Dr Gloria Wong

MBBS, PhD, FRACP
Principal Investigator – Nucleus Network, Brisbane
Specialist General Physician & Clinical Pharmacologist
Senior Lecturer at The University of Queensland

Dr Gloria Wong is a dual-trained General Physician and Clinical Pharmacologist with a PhD in Pharmacology and over a decade of experience in clinical medicine, pharmacokinetics, and early-phase clinical trials. She currently serves as a Principal Investigator at Nucleus Network, where she leads first-in-human Phase 1 trials involving small molecules, monoclonal antibodies, antisense oligonucleotides, and siRNA therapies.

Her research and clinical interests include:

• Therapeutic drug monitoring and beta-lactam dosing optimization in critically ill patients
• Pharmacokinetics and PK/PD modeling
• Polypharmacy management in frail young adults
• Healthcare system improvement for young adults with disabilities

Academic and Research Contributions

• PhD research has directly influenced current clinical practices in antibiotic dosing.
• Published extensively in high-impact journals such as Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.
• ORCID: 0000-0001-9241-6174
• Senior Lecturer at the University of Queensland, contributing to medical education and clinical research mentorship.

Clinical and Leadership Roles

• Staff Specialist at Queensland Health, leading multidisciplinary care for patients with complex co-morbidities.
• Former Research Associate at ApoPharma Inc. (Canada), contributing to preclinical and clinical trial design.
• Active in clinical governance, supervision of junior doctors, and implementation of deprescribing frameworks.

Dr Wong’s work bridges the gap between pharmacological science and patient-centered care, making her a leader in both clinical research and internal medicine.